Cited by 510Sirtuins and Resveratrol in MedicineGenetics, Aging, and Longevity in Model OrganismsHistone Deacetylase Inhibitors Research

Sirtuins, Aging, and Medicine

Open access
Guarente, Leonard·2011·New England Journal of Medicine

Abstract

In this year's Franklin H. Epstein Lecture, Leonard Guarente summarizes the many biologic properties of the sirtuin family of deacetylases and explains why enhancement or inhibition of specific sirtuins may influence many common diseases and longevity.

Integrity signals

Registry

Crossref · 10.1056/nejmra1100831

Cites

88 of 88 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Over-expression of sirtuins in model systems ameliorates a variety of age-related phenotypes including cancer, diabetes and neurodegeneration.

    “Over-expression of sirtuins in model systems ameliorates a variety of age-related phenotypes including cancer, diabetes and neurodegeneration (Guarente, 2011).”

    From Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us? (2012) · cites this paper as Guarente, 2011

  • Sirtuins are key evolutionarily conserved factors linking caloric restriction to longevity.

    “Sirtuins are key evolutionarily-conserved factors linking caloric restriction to longevity.”

    From Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us? (2012) · cites this paper as Guarente, 2011

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Guarente, L.
Affiliations
Massachusetts Institute of Technology (US)
Corresponding author
Guarente, Leonard
Venue
New England Journal of Medicine
Published
2011-06-09
Volume
364
Issue
23
Pages
2235-2244
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2312699414
Cited by
510
References
88
Citations by year
2026: 7 · 2025: 24 · 2024: 24 · 2023: 16 · 2022: 29 · 2021: 35 · 2020: 29 · 2019: 38 · 2018: 39 · 2017: 23 · 2016: 30 · 2015: 43 · 2014: 52 · 2013: 58 · 2012: 50
FWCI
4.65
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
Keywords
sirtuins, sirtuin deacetylase, aging, longevity, disease, sirtuin inhibition, age-related diseases
MeSH terms
Aging, Animals, Cardiovascular Diseases, Humans, Metabolic Diseases, Neoplasms, Reactive Oxygen Species, Sirtuins, Sirtuin 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review